U.S. regulators have authorized a second pill against COVID-19, an antiviral drug from Merck that may help blunt the wave of infections driven by the omicron variant.
The U.S. has authorized the first pill against COVID-19, a Pfizer drug that Americans can take at home to reduce the risk of hospitalization and death.
DHEC reports 570 hospital beds filled with COVID-19 patients this evening, 23% higher than a week ago.
Final data on Pfizer’s experimental treatment for COVID-19 has now been shared with the FDA. It’s part of the company’s application to authorize the pill for emergency use.
Prisma Health is administering the monoclonal antibody treatment to high-risk COVID-19 patients in the Midlands and the Upstate.
The Food and Drug Administration has sent warning letters to companies selling products that falsely claim to treat COVID-19.
The United States Food and Drug Administration is authorizing Regeneron’s antibody cocktail for some patients who test positive for COVID-19.
As COVID-19 cases continue to climb here in the U.S., the FDA has just approved Remdesivir to treat coronavirus patients, though it was only used in hospitals in cases of emergency.
